Latest Zenith Drugs stock price
Zenith Drugs P/E Ratio
ZENITHDRUG • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
9.03
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
9.03
Current Price
₹
EPS (TTM)
₹5.63
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
48.37
Sector Median
27.37
Sector Rank
#9 of 139
Sector Percentile
6.5%
Key P/E Ratio Insights for Zenith Drugs
- Stock appears undervalued with PE of 9.03, suggesting potential buying opportunity
- Trading at discount to sector average PE of 48.37
View the ZENITHDRUG equity price for detailed stock performance.
Related Pages for Zenith Drugs
Additional stock information and data for ZENITHDRUG
Sector P/E Ratio Comparison
Comparing Zenith Drugs with other companies in Healthcare sector
Sector Average
48.37
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |
| Vasundhara Rasayans | VRL | 10.96 | ₹41 | Low |